DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumors. (Q55070800)
Jump to navigation
Jump to search
scientific article published on 7 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumors. |
scientific article published on 7 October 2014 |
Statements
DNA methylation status of key cell-cycle regulators such as CDKNA2/p16 and CCNA1 correlates with treatment response to doxorubicin and 5-fluorouracil in locally advanced breast tumors. (English)
1 reference
1 reference
1 reference
Anne-Lise Børresen-Dale
1 reference
Per Eystein Lønning
1 reference
Vessela N Kristensen
1 reference
Hege Edvardsen
1 reference
Ida Bukholm
1 reference
Nizar Touleimat
1 reference
Jovana Klajic
1 reference
Florence Busato
1 reference
7 October 2014
1 reference
20
1 reference
24
1 reference
6357-6366
1 reference